C. Abernethy Matthew, Officer: Neurocrine Biosciences NBIX Planned sale · Filed 25/01/31

Trade details

Type: Planned sale notice
Stock: Neurocrine Biosciences NBIX
Person: C. Abernethy MatthewOfficer
Planned sale date: 25/01/31
Filed: 25/01/31

$196.7K to be sold

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/01/01~25/03/02

C. Abernethy Matthew's recent trades

Matt AbernethyOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$361K
2,311 sh
$361K
Filed 09/14
Traded 09/14
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$158K
1,352 sh
$158K
Filed 25/02/14
Traded 25/02/13
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$140.9K
1,206 sh
$140.9K
Filed 25/02/14
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$158.4K
1,352 sh
$158.4K
Filed 25/02/13
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$141.3K
1,206 sh
$141.3K
Filed 25/02/13
Traded 25/02/13